IONIS PHARMACEUT reported $1.25B in Loan Capital for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 1.06M 0.78M
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Arrowhead Research ARWR:US $ 0 0
Astellas Pharma 4503:JP Y 111621M 15735M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bluebird Bio BLUE:US $ 0M 0M
Esperion Therapeutics ESPR:US $ 259.08M 402K
Halozyme Therapeutics HALO:US $ 1147.13M 359.03M
Intercept Pharmaceuticals ICPT:US $ 713.86M 3.03M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 641M 5M
Nektar Therapeutics NKTR:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 169M 208.7M
Novartis NOVN:VX SF 23784M 589M
Omeros OMER:US $ 314.36M 454K
Ptc Therapeutics PTCT:US $ 981.44M 5.79M
Regeneron Pharmaceuticals REGN:US $ 2700.7M 0.3M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Ultragenyx Pharmaceutical RARE:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 482.3M 13.2M